Respiratory depression secondary to morphine use in a patient with COPD and refractory breathlessness Source: Eur Respir J, 49 (5) 1601858; 10.1183/13993003.01858-2016 Year: 2017
Attitudes of patients with chronic breathlessness towards treatment with opioids Source: Eur Respir J, 55 (2) 1901752; 10.1183/13993003.01752-2019 Year: 2020
Patient characteristics and triggers eliciting refractory chronic cough Source: International Congress 2018 – Management of chronic cough and respiratory muscle dysfunction Year: 2018
Mechanisms of dyspnoea relief following radiation treatment in a patient with severe COPD Source: Eur Respir J 2011; 38: 728-730 Year: 2011
Nonpharmacological cough control therapy for chronic refractory cough and cough associated with underlying lung disease Source: ERJ Open Res, 6 (1) 00243-2019; 10.1183/23120541.00243-2019 Year: 2020
Adverse respiratory effects of opioids for chronic breathlessness: learning lessons from chronic pain Source: Eur Respir J, 51 (3) 1702531; 10.1183/13993003.02531-2017 Year: 2018
Adverse respiratory effects of opioids for chronic breathlessness: to what extent can we learn lessons from chronic pain? Source: Eur Respir J, 52 (1) 1800882; 10.1183/13993003.00882-2018 Year: 2018
Opioids and adverse outcomes in elderly chronic obstructive pulmonary disease patients Source: Eur Respir J 2016; 48: 1817 Year: 2016
Opioids and adverse outcomes in elderly chronic obstructive pulmonary disease patients Source: Eur Respir J 2016; 48: 1818 Year: 2016
Enough is enough: misuse of NIV in the treatment of chronic patients with exacerbation of symptoms? Source: Annual Congress 2013 –The dark side of the moon: when, why, and where I should not use NIV? Year: 2013
How to manage chronic cough patients Source: ERS Satellites 2021 Year: 2021
Does the presence of acute on chronic hyperventilation predict response to treatment in patients with chronic idiopathic hyperventilation Source: Eur Respir J 2003; 22: Suppl. 45, 88s Year: 2003
Efficacy and response predictors of inhaled corticosteroid treatment on chronic cough Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care Year: 2016
Capsaicin sensitivity in patients with chronic refractory unexplained cough Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura Year: 2011
Sertraline effects on dyspnea in patients with severe COPD Source: Eur Respir J 2005; 26: Suppl. 49, 288s Year: 2005
Dyspnea sensation and health-related quality predict exacerbations, hospitalizations and mortality in patients with chronic respiratory failure receiving long-term oxygen therapy Source: Eur Respir J 2006; 28: Suppl. 50, 519s Year: 2006
Distribution of dyspnea etiologies among patients with either acute or chronic breathlessness and normal cardiorespiratory function Source: Annual Congress 2012 - Distinguishing phenotypes and dealing with comorbidities in primary care Year: 2012
Opioid prescription for severe chronic breathlessness to hospitalised patients with COPD - a clinical audit Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020
The diagnosis and treatment of chronic cough patients Source: Eur Respir J 2005; 26: Suppl. 49, 300s Year: 2005
Physical therapy in the treatment of chronic cough Source: Annual Congress 2012 - PG12 Cough: from basic mechanisms to clinical approaches Year: 2012